AUG 18, 2010
The variety of intraocular lens (IOL) types has grown dramatically during the past decade, which has spurred much debate about appropriate IOL choices in various clinical situations. Aging populations in the developed world are growing, as is their demand for cataract surgery. Older patients are increasingly presenting with existing or potential multiple ocular comorbidities that may impact IOL performance. This raises the question of whether we should consider which IOL types should or shouldn't be offered to patients with early age-related macular degeneration (AMD) or who are at high risk for developing it.